ABVC BioPharma, Inc. Common Stock
$1.08
$0.01 (+0.93%)
$0.98Day Range$1.14
Key Statistics
Market Cap
$28.79M
Shares Outstanding
26.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 9, 2004
Round Lot
100
Locale
US
Trading Data
Day Open
$1.07
Day High
$1.14
Day Low
$0.98
Volume
192.9K
VWAP
$1.07
Prev Close
$1.07
Transactions
--
Acc. Volume
--
About ABVC BioPharma, Inc. Common Stock
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
PHARMACEUTICAL PREPARATIONSSIC 283419 employees44370 OLD WARM SPRINGS BLVD., FREMONT, CA, 94538510-668-0881IPO Nov 9, 2004US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001173313
- Composite FIGI
- BBG000Q844Z2
- Share Class FIGI
- BBG001SMCS49
- Ticker Root
- ABVC
- SIC Code
- 2834
About ABVC BioPharma, Inc. Common Stock (ABVC) Stock
ABVC BioPharma, Inc. Common Stock (ABVC) closed the 2026-09-16 session at $1.08, up 0.93% versus the previous close (+0.01). The stock opened at $1.07 and traded between $0.98 and $1.14 during that session. Session trading volume was 193K shares. The volume-weighted average price (VWAP) is $1.07.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
ABVC BioPharma, Inc. Common Stock has a market capitalization of $28.8 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ABVC is listed on the XNAS exchange. The company employs approximately 19 people. ABVC BioPharma, Inc. Common Stock is headquartered in FREMONT, CA. The recorded listing date is 2004-11-09.
On this page you can find market ABVC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.